Brand Name: SELARSDI. Generic Name: (ustekinumab-aekn). It is used to treat plaque psoriasis (PsO), psoriatic arthritis (PsA), Crohn’s disease (CD), ulcerative colitis(UC).
SELARSDI is a human interleukin-12 and -23 antagonist indicated for the treatment of:
Adult patients with:
• moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy.
• active psoriatic arthritis (PsA).
• moderately to severely active Crohn’s disease (CD).
• moderately to severely active ulcerative colitis.
| Brand Name: | SELARSDI |
| Generic Name: | ustekinumab-aekn |
| Strength: | • Subcutaneous Injection Injection: 45 mg/0.5 mL or 90 mg/mL solution in a single-dose prefilled syringe • Intravenous Infusion Injection: 130 mg/26 mL (5 mg/mL) solution in a single-dose vial |
| Manufacturer: | Teva Pharmaceuticals |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “SELARSDI (ustekinumab-aekn) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.